FENC R&D Expenses
Fennec Pharmaceuticals Inc · R&D Expenses
FENC R&D Expenses
Latest reported$216.00Kperiod ending
FENC TTM R&D Expenses ($1.21M → $216.00K)
TTM R&D Expenses
High-resolution chart · PNG
FENC r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 216,000 | |
| 205,000 | |
| 250,000 | |
| 280,000 | |
| 348,000 | |
| 398,000 | |
| 307,000 | |
| 289,000 | |
| 204,000 | |
| 55,000 | |
| 56,000 | |
| 141,000 | |
| 975,000 | |
| 2,098,000 | |
| 3,531,000 | |
| 3,937,000 | |
| 4,333,000 | |
| 4,002,000 | |
| 4,981,000 | |
| 5,681,000 | |
| 5,807,000 | |
| 6,128,000 | |
| 5,105,000 | |
| 5,054,000 | |
| 4,481,000 | |
| 5,329,000 | |
| 5,607,000 | |
| 6,158,000 | |
| 7,161,000 | |
| 5,990,000 | |
| 5,008,000 | |
| 4,171,000 | |
| 2,865,000 | |
| 2,400,000 | |
| 1,936,000 | |
| 1,224,000 | |
| 844,000 | |
| 650,000 | |
| 472,000 | |
| 369,000 | |
| 345,000 | |
| 260,000 | |
| 256,000 | |
| 350,000 | |
| 350,000 | |
| 368,000 | |
| 357,000 | |
| 282,000 | |
| -30,000 | |
| 452,000 | |
| 598,000 | |
| 1,069,000 | |
| 1,650,000 | |
| 1,956,000 | |
| 2,074,000 | |
| 2,019,000 | |
| 2,101,000 | |
| 1,475,000 | |
| 1,494,000 | |
| 1,277,000 | |
| 948,000 | |
| 860,000 | |
| 708,000 | |
| 556,000 | |
| 493,000 | |
| 997,000 | |
| 2,113,000 | |
| 3,574,000 | |
| 6,348,000 | |
| 8,270,000 | |
| 10,366,000 | |
| 11,387,000 | |
| 11,056,000 | |
| 11,130,000 | |
| 10,912,000 | |
| 12,372,062 | |
| 13,978,062 | |
| 14,600,062 | |
| 14,003,062 | |
| 13,840,439 | |
| 12,891,277 | |
| 12,983,402 | |
| 12,441,385 | |
| 9,926,946 | |
| 8,066,131 | |
| 5,616,218 | |
| 4,783,047 | |
| 4,256,687 | |
| 3,585,160 | |
| 3,753,964 | |
| 3,253,199 | |
| 3,079,789 | |
| 3,418,979 | |
| 3,571,130 | |
| 3,593,973 | |
| 3,388,096 | |
| 3,144,172 | |
| 1,913,005 | |
| 1,206,115 | |
| 1,029,647 |